Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease

The results suggest that dopamine agonist dose and gender are associated with the prognosis of impulse control disorders. Symptoms of depression emerge together with novel impulse control disorders in Parkinson's disease.